TCR2 Therapeutics Inc.

NASDAQ: TCRR · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 10:00 PM

TCR2 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-40.4M -60.51M -30.59M -31.6M -29.12M -27.74M -26.24M -24.31M -21.51M
Depreciation & Amortization
615K 746K 890K 704K 706K 851K 773K 690K 513K
Stock-Based Compensation
579K 2.66M 2.69M 2.85M 3.18M 2.74M 3.19M 3.22M 3.12M
Other Working Capital
-6.9M 3.29M 1.19M 11.63M -7.69M 2.94M 3.17M 176K -3.9M
Other Non-Cash Items
2.57M 27.05M -263K -160K 20K 24.05M 209K 253K 164K
Deferred Income Tax
n/a n/a n/a -314K 21K -6K 42K 27K 36K
Change in Working Capital
-3.37M 5.09M 1.44M 8.99M -5.94M 104K 2.65M 1.08M -2.22M
Operating Cash Flow
-40.01M -24.96M -25.84M -19.53M -31.13M 58.32M -19.38M -19.04M -19.9M
Capital Expenditures
-158K -2.44M -4.82M -6.21M -1.98M 5.18M -2.35M -821K -1.49M
Cash Acquisitions
n/a 15.45M n/a n/a 3.08M n/a n/a n/a 1.8M
Purchase of Investments
-13.7M -51.9M -29.61M -37.62M -148.38M -9.99M n/a n/a -40.73M
Sales Maturities Of Investments
35M 58M 70M 33.5M 32.99M n/a 35.1M 46.23M 59.29M
Other Investing Acitivies
543K -15.45M n/a n/a -3.08M -11.97M n/a n/a -1.8M
Investing Cash Flow
21.69M 3.66M 35.56M -10.33M -117.37M -16.78M 32.76M 45.41M 17.06M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
24K 41K 72K -47K 59K 131K 343K 4.15M 127.51M
Financial Cash Flow
24K 41K 72K -47K 59K 131K 343K 4.15M 127.51M
Net Cash Flow
-18.3M -21.26M 9.79M -29.91M -148.44M -39.93M 13.72M 30.52M 124.68M
Free Cash Flow
-40.17M -27.4M -30.66M -25.74M -33.11M 63.5M -21.73M -19.86M -21.39M